🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Kirana commerce unicorn ElasticRun narrows losses by 60% in FY25

EntrackrEntrackr · 8d ago
Kirana commerce unicorn ElasticRun narrows losses by 60% in FY25
Medial

ElasticRun, a kirana-commerce and logistics platform, stabilised its scale in the fiscal year ending March 2025 after a sharp contraction in the previous year when its revenue had declined by nearly 49%. The company significantly narrowed its losses during the same period. ElasticRun’s gross revenue (GMV) increased 9% to Rs 2,653 crore in FY25, up from Rs 2,435 crore in FY24, according to its consolidated financial statements sourced from the Registrar of Companies (RoC). ElasticRun generates revenue by providing a distribution network that allows kirana stores to access branded goods. The company leverages logistics and technology to streamline distribution, primarily in rural and semi-urban areas, though its footprint has spread to key cities as well now. Income from traded goods, which forms 82% of the operating revenue, grew 7.4% to Rs 2,172 crore in FY25. Income from services surged 17.5% to Rs 477 crore in FY25. Including other income, the company’s total income stood at Rs 2,766 crore in FY25, compared to Rs 2,545 crore in the previous fiscal. On the expense side, cost of materials was ElasticRun’s largest expense, accounting for 73% of the total expense. To the tune of scale, this cost increased 5.1% to Rs 2,118 crore in FY25. Employee benefit expenses declined 17.2% to Rs 207 crore. Freight, handling and servicing costs rose modestly by 4.8% to Rs 457 crore in FY25. Overall, the company’s total expenses rose marginally by 0.2% to Rs 2,911 crore in FY25, compared to Rs 2,904 crore in FY24. The optimization of costs and improvement in high-margin service revenue enabled ElasticRun to narrow its losses by 60% to Rs 145 crore in FY25 from Rs 360 crore in FY24. Its ROCE and EBITDA margin improved to -16.96% and -8.44% respectively. On a unit basis, ElasticRun spent Rs 1.10 to earn a rupee during the year, improving from Rs 1.19 in FY24. The company recorded cash and bank balances of Rs 643 crore, while its current assets stood at Rs 1,566 crore and total assets at Rs 1,659 crore in FY25. According to TheKredible, ElasticRun has raised a total of $461 million of funding till date, having Prosus and Avataar Ventures as its lead investors who own 21.36% and 18.68% of the company respectively.

Related News

Exclusive: Unacademy narrows EBITDA losses by 38% in FY25, reports Rs 826 Cr income

EntrackrEntrackr · 2m ago
Exclusive: Unacademy narrows EBITDA losses by 38% in FY25, reports Rs 826 Cr income
Medial

Unacademy’s total revenue decreased 16% year on year to Rs 826.3 crore in FY25, compared to Rs 988 crore in FY24, according to the internal document reviewed by Entrackr. Despite the year-on-year decrease in total revenue, edtech unicorn Unacademy managed to reduce its EBITDA losses by 37.6% year-on-year in the fiscal year ending March 2025. Moreover, the SoftBank-backed firm also reduced its net losses by 31% year-on-year to Rs 436 crore in FY25. The firm’s EBITDA loss was Rs 305 crore, down from Rs 489 crore in FY24, a 38% reduction due to cost optimization measures. As of March 2025, Unacademy had a cash and cash equivalent balance of Rs 1,238 crore. Recently, Unacademy elevated Sumit Jain, co-founder and head of its Graphy subsidiary, as CEO of its flagship Test Prep business.

Redcliffe Labs posts Rs 419 Cr revenue in FY25; narrows EBITDA losses

EntrackrEntrackr · 5m ago
Redcliffe Labs posts Rs 419 Cr revenue in FY25; narrows EBITDA losses
Medial

Redcliffe Labs posts Rs 419 Cr revenue in FY25; narrows EBITDA losses Diagnostics platform Redcliffe Labs has posted a 20% increase in its operating revenue to Rs 419 crore in FY25 from Rs 350 crore in FY24 and managed to narrow its EBITDA losses, as per the company’s press release. Diagnostics platform Redcliffe Labs has posted a 20% increase in its operating revenue to Rs 419 crore in FY25 from Rs 350 crore in FY24, as per the company’s press release. The Gurugram-based firm also managed to reduce its EBITDA losses from -38% to -21% during the same period. Founded by Aditya Kandoi, Redcliffe operates a nationwide network of over 80 labs and claims to have the widest home sample collection footprint in the country. Diagnostic services contributed over 95% of the company’s revenue in FY25, with the rest coming from product sales and other operating income. The company said it diagnosed over 2.5 million cases last fiscal and continues to focus on expanding in underserved regions, with more than 70% of its testing volumes now coming from Tier II cities and beyond. On the profitability front, Redcliffe reported a gross margin of 70% in FY25 and is aiming to expand it to 74% in FY26. It has also set a revenue target of Rs 560 crore for the ongoing fiscal through organic growth and strategic acquisitions. “We are transforming lives and making diagnostics a first-line solution for millions who were previously underserved,” said Kandoi. The company plans to expand its presence to over 300 cities with 150 labs by FY28. According to startup data platform TheKredible, Redcliffe has raised $113 million to date, including a $42 million Series C round led by LeapFrog. It also acquired Bengaluru-based Celara Diagnostics in a $7 million deal. Redcliffe competes with players like PharmEasy-owned Thyrocare, Tata 1mg, and Healthians.

Download the medial app to read full posts, comements and news.